Searched for
ZEMBRACESYMTOUCH
Dr Reddy's migraine injection enters US marketDr Reddy's Laboratories (DRL) today said its acute migraine treatment injection ZembraceSymTouch is now commercially available in the US ma...- Dr Reddy's Lab shares gain over 3% on USFDA nod for productThe stock gained 3.21 per cent to settle at Rs 3,103.60 on BSE. Intra-day, it rose 3.58 per cent to Rs 3,115.
- Dr Reddy's gets USFDA nod for migraine injectionThe company has received an approval from the US Food and Drug Administration (USFDA) for ZembraceSymTouch injection, DRL said in a stateme...
- Load More